Ginsenosides analysis in the crude saponin fraction extracted from Korean red ginseng, and its efficacious analysis against acute pulmonary inflammation in mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In this study, we isolated ginseng crude saponin (GCS) from Korean red ginseng (KRG) and determined the ginsenoside content in it to investigate the physiological and pathological effects of GCS on acute pulmonary inflammation induced by intratracheal instillation of cigarette smoke condensates (CSC) and lipopolysaccharide (LPS) solution in BALB/c mice. GCS was orally administered at doses of 10 mg/kg and 25 mg/kg for 3 weeks. The recovery rate of GCS from KRG was 6.5 % and total ginsenosides from GCS was 1.13 %, and the content of Rb1 was the highest among them. Total inflammatory cells in the lung homogenates and bronchoalveolar lavage fluid (BALF) increased following intratracheal administration of CSC and LPS. However, GCS administration impaired this increase. Furthermore, it inhibited the increase in leukocytes in the blood, considerably decreased neutrophils in BALF, and declined infiltration of inflammatory cells and deposition of collagen in the tracheal and alveolar tissue. In this study, GCS was found to have a protective effect against acute pulmonary inflammation and it may be beneficial in preventing various respiratory diseases.
Abstract
In this study, we isolated ginseng crude saponin (GCS) from Korean red ginseng (KRG) and determined the ginsenoside content in it to investigate the physiological and pathological effects of GCS on acute pulmonary inflammation induced by intratracheal instillation of cigarette smoke condensates (CSC) and lipopolysaccharide (LPS) solution in BALB/c mice. GCS was orally administered at doses of 10 mg/kg and 25 mg/kg for 3 weeks. The recovery rate of GCS from KRG was 6.5 % and total ginsenosides from GCS was 1.13 %, and the content of Rb1 was the highest among them. Total inflammatory cells in the lung homogenates and bronchoalveolar lavage fluid (BALF) increased following intratracheal administration of CSC and LPS. However, GCS administration impaired this increase. Furthermore, it inhibited the increase in leukocytes in the blood, considerably decreased neutrophils in BALF, and declined infiltration of inflammatory cells and deposition of collagen in the tracheal and alveolar tissue. In this study, GCS was found to have a protective effect against acute pulmonary inflammation and it may be beneficial in preventing various respiratory diseases.
참고문헌 (34)
- T. K. Yun, , J. Kor. Med. Sci., 16, pp.S3~ (2001)
- 홍미건, "Anti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver disease", Journal of Ginseng Research, 40(3), pp.203~210 (2016), 고려인삼학회
- 정수임, "In Vitro and In Vivo Antioxidant Activity of Aged Ginseng (Panax ginseng)", Preventive Nutrition and Food Science, 21(1), pp.24~30 (2016), 한국식품영양과학회[DOI]
- Jae Gwang Park, "Korean Red Ginseng water extract arrests growth of xenografted lymphoma cells", Journal of Ginseng Research, 40(4), pp.431~436 (2016), 고려인삼학회
- H. U. Lee, , Liver Int, 25(5), pp.1069~1073 (2005)
- 김대현, "Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-kB in LPS-stimulated RAW264.7 cells and mouse liver", Journal of Ginseng Research, 37(1), pp.54~63 (2013), 고려인삼학회
- J. H. Kim, , Physiol. Res, 65(6), pp.1031~1037 (2016)
- J. Bousquet, , Eur. Respir. J, 36(5), pp.995~1001 (2010)
- Heeyoung Oh, "Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease among Nonsmokers: Fifth Korea National Health and Nutrition Examination Survey (2010-2012)", Osong Public Health and Research Persptectives, 7(6), pp.385~393 (2016), 질병관리본부
- J. Lee., , Int. J. Chron. Obstruct Pulmon Dis, 12, pp.27~33 (2016)
- J. Vestbo, , Am. J. Respir Crit. Care Med, 187(4), pp.347~365 (2013)
- M. Maskey-Warzechowska, , Adv. Exp. Med. Biol, 944, pp.73~78 (2017)
- M. Kaur, , J. Pharmacol. Exp. Ther, 347(11), pp.173~180 (2013)
- K. H. Lee, , J. Biol. Chem, 290(47), pp.28438~28445 (2015)
- A. Bhowmik, , JA, Thorax., 55(2), pp.114~120 (2000)
- J. C. Hogg, , New. Eng. J. Med, 350(26), pp.2645~2653 (2004)
- D. Raghavan, , Curr. Opin. Pulm. Med, 22(2), pp.106~112 (2016)
- O. Kornmann, , Eur. Respir. J, 37(2), pp.273~279 (2011)
- S. Apikoglo-Rabus, , Respir. Med, 120, pp.109~115 (2016)
- H. W. Ryu, , Cytokine, 91, pp.57~64 (2016)
- H. G. Kwak, , Chin. J. Nat. Med, 12(9), pp.641~647 (2014)
- S. K. Kim, , J. Ginseng Res, 22(3), pp.155~160 (1998)
- S. Shibata, , Chem. Pharm. Bull. (Tokyo), 14(6), pp.595~600 (1966)
- X. Wang, , Anal. Chem, 71(8), pp.1579~1584 (1999)
- Y. Chen, , Int. Immunopharmacol, 28(2), pp.1097~1101 (2017)
- H. Lee, , Int. Immunopharmacol, 28(2), pp.1097~1101 (2015)
- K. Kuwano, , Respir. Investig, 54(6), pp.397~406 (2016)
- L. Cooling, , J. Clin. Apheresis, 32(1), pp.35~48 (2017)
- D. D. Sin, , Circulation, 107(11), pp.1514~1519 (2003)
- N. Takabatake, , Am. J. Respir. Crit. Care Med, 161(4), pp.1179~1184 (2000)
- I. S. Shin, , Int. Immunopharmacol, 30, pp.62~68 (2016)
- P. J. Barnes, , Europ. Respir. J, 22(4), pp.672~688 (2003)
- J. L. Wright, , Histopathology, 49(1), pp.1~9 (2006)
- T. Min, , J. Molec. Med, 86(6), pp.577~593 (2011)